The Food and Drug Administration’s top lawyers came under fire from Congress last week for apparently writing a memo authorizing a program to conduct surveillance on agency scientists who expressed safety concerns about medical products.
Senator Chuck Grassley (R-Iowa) said in a letter last week that his office received information that an FDA official got legal advice about a program about monitoring email of employees, including emails sent to Grassley’s and other congressional offices. Grassley demanded that the FDA immediately provide him with the memo a lawyer drafted, in a letter that not only takes the FDA to task for the “massive spying campaign” but reminds the agency that interfering with a congressional inquiry is against the law.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
